MCM
GOSS icon

MAI Capital Management’s Gossamer Bio GOSS Stock Holding History

MAI Capital Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.42K Sell
260
-22
-8% -$491 ﹤0.01% 2105
2026
Q1 		$7.42K Buy
282
+281
+28,100% +$35.3K ﹤0.01% 3313
2025
Q4 		$264 Buy
+1
New +$228 ﹤0.01% 3987

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

MAI Capital Management's GOSS Position: Q2 2026 in Review

MAI Capital Management reduced its Gossamer Bio (GOSS) stake by 7.8% in Q2 2026, selling an estimated $491 and leaving 260 shares worth $3.42K. The position accounts for ﹤0.01% of the portfolio, ranked #2105.

MAI Capital Management first reported a position in GOSS in Q4 2025 and has held it in 3 quarters since. The position peaked at $7.42K in Q1 2026. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • MAI Capital Management held 260 shares of Gossamer Bio worth $3.42K as of Q2 2026.
  • MAI Capital Management sold 22 Gossamer Bio shares in Q2 2026, an estimated $491.
  • Gossamer Bio made up ﹤0.01% of MAI Capital Management's portfolio in Q2 2026, its #2105 holding.
  • MAI Capital Management first reported a position in Gossamer Bio in Q4 2025 and has held it in 3 quarters since.
  • MAI Capital Management's Gossamer Bio position peaked at $7.42K in Q1 2026.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.